Average Co-Inventor Count = 6.13
ph-index = 2
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Methylgene, Inc. (9 from 53 patents)
2. Other (1 from 832,843 patents)
3. Mirati Therapeutics, Inc. (1 from 38 patents)
4. Aduro Biotech Inc. (1 from 29 patents)
5. Elkimia, Inc. (1 from 1 patent)
13 patents:
1. 12466838 - Crystalline form of a multi-tyrosine kinase inhibitor, method of preparation, and use thereof
2. 10738056 - Pyrazolopyrimidinone compounds and uses thereof
3. 9636298 - Prodrugs of compounds that enhance antifungal activity and compositions of said prodrugs
4. 9487474 - Imino compounds as protecting agents against ultraviolet radiations
5. 9018378 - Processes and intermediates for preparing fused heterocyclic kinase inhibitors
6. 8906852 - Inhibitors of protein tyrosine kinase activity
7. 8907091 - Processes and intermediates for preparing fused heterocyclic kinase inhibitors
8. 8470850 - Inhibitors of VEGF receptor and HGF receptor signalling
9. 8455484 - Selected inhibitors of protein tyrosine kinase activity
10. 8329726 - Inhibitors of VEGF receptor and HGF receptor signaling
11. 8093264 - Fused heterocycles as inhibitors of VEGF receptor and HGF receptor signaling
12. 7790729 - Inhibitors of VEGF receptor and HGF receptor signaling
13. 7772247 - Substituted thieno[3,2-d]pyridines as inhibitors of the VEGF receptor and HGF receptor